Home  /  Services  /  Bioinformatics

Bioinformatics that turns complex data into clinical insight.

Data mining, signal processing and machine learning applied to clinical and device data — optimising device performance and unlocking the patient-care insights hidden in your datasets.

GHP 2024 · Best Bioinformatic & Biostatistical Consultancy — UK
Pipette sampling a DNA sequencing gel in a genomics lab Data · Models · Evidence
How we work

From raw signals to defensible evidence.

A documented, reproducible pipeline — every step validated, every output traceable back to the raw data.

Step 01 · Ingest

Data Intake

Clinical, sensor and omics data cleaned and structured for analysis.

CleaningQC
Step 02 · Structure

Harmonisation

Multi-source datasets aligned into coherent, analysis-ready form.

IntegrationFeatures
Step 03 · Model

Modelling

ML, statistical modelling and biomarker discovery — built for your question.

ML / AIBiomarkers
Step 04 · Validate

Validation

Calibration, benchmarking and performance assessment regulators accept.

ROCBenchmarks
Step 05 · Evidence

Reporting

Interpreted figures and reports for clinical teams, investors and regulators.

FiguresReports
Capabilities

Analysis across the device data landscape.

Purpose-built analyses for device developers — every pipeline documented, validated and reproducible.

C.01

Data Mining & Signal Processing

Extracting meaningful patterns from high-volume clinical, sensor and device data — cleaned, structured and analysis-ready.

C.02

Machine Learning & AI

Predictive modelling and classification for diagnostics and device optimisation — with validation strategies regulators accept.

C.03

Biomarker Discovery

Identification and statistical validation of biomarkers for advanced diagnostic development, including liquid biopsy programmes.

C.04

Algorithm Validation

Calibration, benchmarking and performance assessment for SaMD and AIaMD — sensitivity, specificity, ROC and beyond.

C.05

Multi-Source Data Integration

Combining clinical, omics and real-world datasets into coherent analyses that support your evidence claims.

C.06

Device Performance Analytics

Longitudinal and comparative performance analysis across patient populations and use conditions.

C.07

Reproducible Pipelines

Versioned, documented R and Python workflows — auditable, repeatable and ready for inspection.

C.08

Visualisation & Reporting

Clear, publication-grade figures and interpreted reports for clinical teams, investors and regulators.

What you receive

Analyses you can defend.

Every output is documented end-to-end — methods, code and interpretation in one package.

D.01

Analysis Plan

Objectives, data sources, methods and validation strategy agreed up front.

D.02

Validated Models

Trained, tested and benchmarked models with documented performance characteristics.

D.03

Biomarker Evidence

Statistical validation summaries ready for regulatory and publication use.

D.04

Reproducible Code

Annotated R/Python pipelines with version control and run instructions.

D.05

Figures & Reports

Interpreted, publication-grade outputs written for technical and clinical readers.

D.06

Submission Support

Responses to analytical questions from regulators and notified bodies.

Schedule a Discovery Call

Next step

Bring us your dataset — we’ll find the signal.

A no-obligation conversation with a lead bioinformatician. If we’re the right fit, we’ll prepare a complete proposal for the work — nothing is committed until the contract is signed.

Schedule a Discovery Call
Want to know more first?
REF.01Your device context

Could bioinformatics enhance your R&D?

Bioinformatics is redefining the capabilities of medtech. By analysing large-scale biological data, it enables devices and solutions to be more precise, adaptive and patient-centred — here is how it supports research and development across diagnostics, therapeutics, software-based medical solutions and aesthetics.

Diagnostics

Diagnostic Devices

Bioinformatics in diagnostics allows for earlier, more accurate disease detection and personalised patient assessments.

Risk prediction models — algorithms that predict disease risk from patient data, identifying high-risk individuals and guiding preventive measures.
Biomarker discovery & validation — disease markers that improve diagnostic accuracy, supporting personalised testing and early intervention.
Pathogen detection & metagenomics — genetic material analysis to detect pathogens and monitor microbiome health, enabling efficient point-of-care diagnostics.
Therapeutics

Therapeutic Devices

Therapeutic devices increasingly rely on bioinformatics to adapt treatments to patient needs, enabling more personalised care.

Optimised device–patient interaction — patient data captured by the device is processed to fine-tune settings and provide real-time feedback for adaptive treatment.
Remote monitoring & adaptive therapies — continuous patient data lets therapeutic devices adjust in real time based on patient-specific responses.
Precision medicine — genetic and clinical data analysed to tailor device settings, improving treatment efficacy and patient response.
SaMD / AIaMD

Software & AI as a Medical Device

Bioinformatics plays a crucial role in AI-driven diagnostics and predictive models, offering insights for personalised treatment planning.

Image & signal analysis — bioinformatics-powered AI for complex medical imaging or signals (MRI, ECG) supporting early diagnosis and monitoring.
Clinical decision support — bioinformatic insight integrated into clinical tools, combining genetic and lifestyle data to guide patient management.
Predictive & diagnostic algorithms — AI models that analyse patient data, such as genomic profiles, to predict disease risk or suggest customised interventions.
Aesthetics

Aesthetic Medicine

Bioinformatics enables personalised aesthetic treatments by leveraging individual biological data.

Treatment monitoring & efficacy tracking — biomarker data analysed to evaluate the long-term effectiveness of aesthetic treatments, informing ongoing care.
Genetic profiling for personalised treatments — treatments tailored to genetic predispositions such as skin ageing and collagen loss.
Skin microbiome analysis — skin health assessed at the microbiome level, supporting individualised skincare and treatment regimens.
Our goal is to make bioinformatics an accessible, integral part of your medtech research — from concept to final analysis.
REF.03The inflection point

The leap from raw sequence to validated target defines the entire research trajectory.

Secure the computational rigour required to validate your biomarker hypothesis and advance with clarity — we will design the exact bioinformatics architecture your discovery demands, to maximise your insights and expand what’s possible.

Schedule a Discovery Call